IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas

Autor: Deckert, Jutta, Thirlway, Jenny *, Mysliwy, Justyna *, Lodge, Adam *, Park, Yun-Hee *, Ryu, Hyun-Min *, Han, Na Ra *, Song, Ho Young *, Chung, Chul-Woong *, Lutz, Robert J
Zdroj: In Blood 15 November 2022 140 Supplement 1:3134-3135
Databáze: ScienceDirect